Rhythm Pharma's obesity drug fails to meet main goal in late-stage trial-March 2024-www.financetom.com

Rhythm Pharma's obesity drug fails to meet main goal in late-stage trial

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Rhythm Pharma's obesity drug fails to meet main goal in late-stage trial

Mar 16, 2026 1:34 PM

March 16 (Reuters) - Rhythm Pharmaceuticals ( RYTM )

said on Monday its experimental obesity drug in patients with

rare genetic conditions did not meet the main goal of a

late-stage trial.

Previous page： LIC awaits regulatory clarity to re-enter mediclaim segment Next page： Trell is not being investigated for any financial irregularity: co-founder

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

LIC awaits regulatory clarity to re-enter mediclaim segment

Aug 14, 2022

Debasish Panda, the new chairman of Irdai, recently said it was time for life insurers to return to the health insurance market because he had mandated that the sector makes sure that every person had health insurance by the year 2030.

Trell is not being investigated for any financial irregularity: co-founder

Aug 14, 2022

Founded by Agrawal, Bimal Kartheek Rebba, Arun Lodhi, and Prashant Sachan (who exited the company in mid-2020), Trell allows users to create content related to beauty or lifestyle products and post it on the platform.

Fairfax-backed Go Digit Insurance to file IPO DRHP this week, say sources

Aug 13, 2022

The general insurance company is expected to raise Rs 5,000 crore via issuance of 15 percent equity.

Oil prices ease as Aramco says ready to boost crude output

Aug 15, 2022

Oil prices dropped for a second session on Monday after the head of the world's top exporter, Saudi Aramco, said it is ready to ramp up output while production at several offshore U.S. Gulf of Mexico platforms is resuming after a brief outage last week.